Rosana Kapeller, Rome CEO

Rosana Kapeller rais­es $77M in bid to make re­peatome drugs a re­al­i­ty

Giv­en the choice, Rosana Kapeller would have picked dif­fer­ent cir­cum­stances to be a first time founder-CEO.

The long­time com­pu­ta­tion­al bi­ol­o­gist, an ear­ly vet­er­an of Mil­len­ni­um and Nim­bus, be­gan putting to­geth­er her lat­est ven­ture in late 2019, rais­ing the Se­ries A for Rome Ther­a­peu­tics in the win­ter and ear­ly spring of 2020. And then, of course, the world shut down.

Kapeller, sprite­ly but forth­right, ac­knowl­edges it’s been a strug­gle. She went a year with­out see­ing most of the team she was build­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.